Stocks and Investing
Stocks and Investing
Thu, November 10, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, November 9, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Reni Benjamin Maintained (BCYC) at Buy with Decreased Target to $46 on, Nov 9th, 2022
Reni Benjamin of JMP Securities, Maintained "Bicycle Therapeutics plc" (BCYC) at Buy with Decreased Target from $70 to $46 on, Nov 9th, 2022.
Reni has made no other calls on BCYC in the last 4 months.
There are 5 other peers that have a rating on BCYC. Out of the 5 peers that are also analyzing BCYC, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $45 on, Monday, September 12th, 2022
These are the ratings of the 4 analyists that currently disagree with Reni
- Tara Bancroft of "Cowen & Co." Initiated at Buy on, Wednesday, August 31st, 2022
- Jonathan Chang of "SVB Leerink" Maintained at Buy with Increased Target to $50 on, Monday, August 22nd, 2022
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $57 on, Friday, August 5th, 2022
- Peter Lawson of "Barclays" Initiated at Buy and Held Target at $30 on, Thursday, July 28th, 2022
Contributing Sources